Literature DB >> 20483720

Increased hematopoietic cells in the mertk-/- mouse peritoneal cavity: a result of augmented migration.

Julie C Williams1, Nikki J Wagner, H Shelton Earp, Barbara J Vilen, Glenn K Matsushima.   

Abstract

The peritoneal cavity is recognized as an important site for autoreactive B cells prior to their transit to other immune tissues; however, little is known of the genes that may regulate this process. Mice lacking the receptor tyrosine kinase, Mertk, display a lupus-like autoimmune phenotype with splenomegaly and high autoantibodies titers. In this study, we investigate whether Mertk regulates the composition of peritoneal cells that favor an autoimmune phenotype. We found an increase in the number of macrophages, dendritic cells (DCs), plasmacytoid DCs, T cells, and B cells in the peritoneal cavity of mertk-/- mice when compared with wild-type mice. This disparity in cell numbers was not due to changes in cell proliferation or cell death. In adoptive transfer experiments, we showed an increase in migration of labeled donor cells into the mertk-/- peritoneal cavity. In addition, bone marrow chimeric mice showed hematopoietic-derived factors were also critical for T cell migration. Consistent with this migration and the increase in the number of cells, we identified elevated expression of CXCL9, its receptor CXCR3, and IL-7R on peritoneal cells from mertk-/- mice. To corroborate the migratory function of CXCR3 on cells, the depletion of CXCR3 donor cells significantly reduced the number of adoptively transferred cells that entered into the peritoneum of mertk-/- mice. This control of peritoneal cells numbers correlated with autoantibody production and was exclusively attributed to Mertk because mice lacking other family members, Axl or Tyro 3, did not display dysregulation in peritoneal cell numbers or the autoimmune phenotype.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20483720      PMCID: PMC2891427          DOI: 10.4049/jimmunol.0902784

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  45 in total

1.  Peritoneal and splenic B-1 cells are separable by phenotypic, functional, and transcriptomic characteristics.

Authors:  Joseph R Tumang; William D Hastings; Chunyan Bai; Thomas L Rothstein
Journal:  Eur J Immunol       Date:  2004-08       Impact factor: 5.532

2.  Impaired clearance of apoptotic cells induces the activation of autoreactive anti-Sm marginal zone and B-1 B cells.

Authors:  Ye Qian; Hongsheng Wang; Stephen H Clarke
Journal:  J Immunol       Date:  2004-01-01       Impact factor: 5.422

3.  Description of B lymphocytes and plasma cells, complement, and chemokines/receptors in acute liver allograft rejection.

Authors:  Manfred G Krukemeyer; Johannes Moeller; Lars Morawietz; Birgit Rudolph; Ulf Neumann; Tom Theruvath; Peter Neuhaus; Veit Krenn
Journal:  Transplantation       Date:  2004-07-15       Impact factor: 4.939

4.  Cloning and mRNA expression analysis of a novel human protooncogene, c-mer.

Authors:  D K Graham; T L Dawson; D L Mullaney; H R Snodgrass; H S Earp
Journal:  Cell Growth Differ       Date:  1994-06

5.  Defective B1 cell homing to the peritoneal cavity and preferential recruitment of B1 cells in the target organs in a murine model for systemic lupus erythematosus.

Authors:  Toshihiro Ito; Sho Ishikawa; Taku Sato; Kenji Akadegawa; Hideaki Yurino; Masahiro Kitabatake; Shigeto Hontsu; Taichi Ezaki; Hiroshi Kimura; Kouji Matsushima
Journal:  J Immunol       Date:  2004-03-15       Impact factor: 5.422

6.  Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells.

Authors:  Susan M Kaech; Joyce T Tan; E John Wherry; Bogumila T Konieczny; Charles D Surh; Rafi Ahmed
Journal:  Nat Immunol       Date:  2003-11-16       Impact factor: 25.606

7.  The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases.

Authors:  T N Stitt; G Conn; M Gore; C Lai; J Bruno; C Radziejewski; K Mattsson; J Fisher; D R Gies; P F Jones
Journal:  Cell       Date:  1995-02-24       Impact factor: 41.582

8.  Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase.

Authors:  Philip L Cohen; Roberto Caricchio; Valsamma Abraham; Todd D Camenisch; J Charles Jennette; Robert A S Roubey; H Shelton Earp; Glenn Matsushima; Elizabeth A Reap
Journal:  J Exp Med       Date:  2002-07-01       Impact factor: 14.307

9.  Overlapping roles of CXCL13, interleukin 7 receptor alpha, and CCR7 ligands in lymph node development.

Authors:  Sanjiv A Luther; K Mark Ansel; Jason G Cyster
Journal:  J Exp Med       Date:  2003-05-05       Impact factor: 14.307

10.  The "Ly-1 B" cell subpopulation in normal immunodefective, and autoimmune mice.

Authors:  K Hayakawa; R R Hardy; D R Parks; L A Herzenberg
Journal:  J Exp Med       Date:  1983-01-01       Impact factor: 14.307

View more
  10 in total

1.  Resident peritoneal NK cells.

Authors:  Rosemary Gonzaga; Polly Matzinger; Ainhoa Perez-Diez
Journal:  J Immunol       Date:  2011-11-11       Impact factor: 5.422

2.  Immune modulation of vascular resident cells by Axl orchestrates carotid intima-media thickening.

Authors:  Janice Gerloff; Vyacheslav A Korshunov
Journal:  Am J Pathol       Date:  2012-05       Impact factor: 4.307

Review 3.  The TAM family: phosphatidylserine sensing receptor tyrosine kinases gone awry in cancer.

Authors:  Douglas K Graham; Deborah DeRyckere; Kurtis D Davies; H Shelton Earp
Journal:  Nat Rev Cancer       Date:  2014-12       Impact factor: 60.716

4.  Complement component C1q regulates macrophage expression of Mer tyrosine kinase to promote clearance of apoptotic cells.

Authors:  Manuel D Galvan; Deborah B Foreman; Erliang Zeng; John C Tan; Suzanne S Bohlson
Journal:  J Immunol       Date:  2012-03-14       Impact factor: 5.422

5.  An AXL/LRP-1/RANBP9 complex mediates DC efferocytosis and antigen cross-presentation in vivo.

Authors:  Manikandan Subramanian; Crystal D Hayes; Joseph J Thome; Edward Thorp; Glenn K Matsushima; Joachim Herz; Donna L Farber; Kang Liu; Madepalli Lakshmana; Ira Tabas
Journal:  J Clin Invest       Date:  2014-02-10       Impact factor: 14.808

6.  Increased Mer and Axl receptor tyrosine kinase expression on glomeruli in lupus nephritis.

Authors:  Shanshan Li; Qianyu Guo; Huaqun Zhu; Zhanguo Li; Yin Su; Bao Dong
Journal:  Clin Rheumatol       Date:  2017-01-26       Impact factor: 2.980

7.  Intrinsic unresponsiveness of Mertk-/- B cells to chronic graft-versus-host disease is associated with unmodulated CD1d expression.

Authors:  Wen-Hai Shao; Yuxuan Zhen; Fred D Finkelman; Robert A Eisenberg; Philip L Cohen
Journal:  J Autoimmun       Date:  2012-07-31       Impact factor: 7.094

8.  MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunity.

Authors:  Alisa B Lee-Sherick; Kristen M Jacobsen; Curtis J Henry; Madeline G Huey; Rebecca E Parker; Lauren S Page; Amanda A Hill; Xiaodong Wang; Stephen V Frye; H Shelton Earp; Craig T Jordan; Deborah DeRyckere; Douglas K Graham
Journal:  JCI Insight       Date:  2018-11-02

9.  Effect of PAR-2 Deficiency in Mice on KC Expression after Intratracheal LPS Administration.

Authors:  Julie C Williams; Rebecca D Lee; Claire M Doerschuk; Nigel Mackman
Journal:  J Signal Transduct       Date:  2011-12-07

10.  Inflammatory mediator profiling reveals immune properties of chemotactic gradients and macrophage mediator production inhibition during thioglycollate elicited peritoneal inflammation.

Authors:  Derek Lam; Devon Harris; Zhenyu Qin
Journal:  Mediators Inflamm       Date:  2013-03-31       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.